» Articles » PMID: 17459456

A Common Variant of the P16(INK4a) Genetic Region is Associated with Physical Function in Older People

Abstract

p16(INK4a) is active in cell senescence, ageing and tumor suppression. Deletion of the small p16(INK4a)/ARF/p15(INK4b) region occurs in many cancers. We screened 25 common polymorphisms across the region and three related genes for associations with physical functioning in older people. In an initial sample of 938 (aged 65-80 years) from the EPIC study (Norfolk, UK), the rs2811712 SNP minor allele (located between the shared p16(INK4a)/ARF locus and p15(INK4b)) was associated with reduced physical impairment. This association remained after testing an additional 1319 EPIC-Norfolk samples (p-value=0.013, total n=2257), and on independent replication in the InCHIANTI study (n=709, p=0.015), and at one-sided significance in Iowa-EPESE (n=419, p=0.079). Overall (n=3372), the prevalence of severely limited physical function was 15.0% in common homozygotes and 7.0% in rare homozygotes (per minor allele odds ratio=1.48, 95% CI: 1.17-1.88, p=0.001, adjusted for age, sex and study). This estimate was similar excluding screening set 1 (OR=1.45, 95% CI: 1.09-1.92, p=0.010, n=2434). These findings require further replication, but provide the first direct evidence that the p16(INK4a)/ARF/p15(INK4b) genetic region and the senescence machinery are active in physical ageing in heterogeneous human populations. The mechanism involved may be via greater cellular restorative activity and reduced stem cell senescence.

Citing Articles

Structural analysis of the impact of germline mutations of p16 in melanoma prone families.

Arun D, Rath S Mol Divers. 2025; .

PMID: 39821174 DOI: 10.1007/s11030-024-11089-z.


The Role of p16Ink4a as an Early Predictor of Physiological Decline during Natural Aging.

Tang L, Hladyshau S, Ross A, Nyrop K, Entwistle A, Muss H medRxiv. 2024; .

PMID: 39606419 PMC: 11601678. DOI: 10.1101/2024.11.21.24317752.


Post-GWAS functional analysis identifies CUX1 as a regulator of p16 and cellular senescence.

Jiang D, Sun W, Wu T, Zou M, Vasamsetti S, Zhang X Nat Aging. 2023; 2(2):140-154.

PMID: 37117763 PMC: 10154215. DOI: 10.1038/s43587-022-00177-0.


p16 a biomarker of aging and tolerance for cancer therapy.

Muss H, Smitherman A, Wood W, Nyrop K, Tuchman S, Randhawa P Transl Cancer Res. 2022; 9(9):5732-5742.

PMID: 35117935 PMC: 8797727. DOI: 10.21037/tcr.2020.03.39.


Potential Nutrients from Natural and Synthetic Sources Targeting Inflammaging-A Review of Literature, Clinical Data and Patents.

Koppula S, Akther M, Haque M, Kopalli S Nutrients. 2021; 13(11).

PMID: 34836313 PMC: 8617641. DOI: 10.3390/nu13114058.


References
1.
Carmelli D, Wolf P, Swan G, Jack L, Reed T, Guralnik J . The contribution of genetic influences to measures of lower-extremity function in older male twins. J Gerontol A Biol Sci Med Sci. 2000; 55(1):B49-53. DOI: 10.1093/gerona/55.1.b49. View

2.
Reed T, Fabsitz R, Selby J, Carmelli D . Genetic influences and grip strength norms in the NHLBI twin study males aged 59-69. Ann Hum Biol. 1991; 18(5):425-32. DOI: 10.1080/03014469100001722. View

3.
. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Br J Cancer. 2000; 83(10):1301-8. PMC: 2408797. DOI: 10.1054/bjoc.2000.1407. View

4.
Ferrucci L, Bandinelli S, Benvenuti E, Di Iorio A, Macchi C, Harris T . Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc. 2000; 48(12):1618-25. DOI: 10.1111/j.1532-5415.2000.tb03873.x. View

5.
Barzilai N, Shuldiner A . Searching for human longevity genes: the future history of gerontology in the post-genomic era. J Gerontol A Biol Sci Med Sci. 2001; 56(2):M83-7. DOI: 10.1093/gerona/56.2.m83. View